smartTrade Acquires Celoxica to Expand Its Multi-Asset Trading and Payments Ecosystem
smartTrade has acquired Celoxica to expand its multi-asset trading and payments ecosystem into listed markets. The acquisition adds Celoxica’s ultra-low latency execution technology to smartTrade’s trading, FX derivatives, and payments solutions. The deal brings together two companies that operate at complementary levels of the front-office technology stack.
Ultra-Low Latency Execution
Celoxica provides ultra-low latency execution solutions for listed equities, futures, fixed income, and options. Its technology includes software and FPGA-accelerated feed handlers, market access gateways, and execution engines. Also, the company offers in-line pre-trade risk capabilities in more than 80 trading venues. It operates as a fully managed service provider for banks, prime brokers, hedge funds, and quantitative trading firms. smartTrade adds specialised execution infrastructure to its technology offering by acquiring Celoxica.
OTC and Listed Markets
The acquisition fuses the companies' complementary capabilities across the front-office stack. smartTrade provides workflow orchestration, pricing, and distribution through its three business areas:
- Trading through LiquidityFX.
- FX Derivatives through kACE.
- Payments through Commercial Banking & Payments.
Celoxica adds risk management and execution infrastructure to this offering.
Together, the companies can cover OTC and listed markets. Their merged capabilities extend from workflow orchestration and pricing to risk management and execution.
Leadership and Client Relationships
Jean-Marc Bouhelier will keep leading Celoxica and will join the smartTrade Executive Committee. The acquisition will not change Celoxica's current client relationships, contracts, or support arrangements. Also, it will create opportunities for both companies' customers. smartTrade's more than 250 clients will get access to Celoxica's execution technology. Meanwhile, Celoxica's clients will get access to the wider Group's trading, payments, and AI capabilities.
What Executive Said
David Vincent, CEO and Co-Founder of smartTrade, explained that the acquisition toughen the company's ambition to become a preferred technology partner for electronic trading and payments. He stressed that adding Celoxica's specialised ultra-low latency execution infrastructure will expand smartTrade's global, multi-asset offering. The deal lets the company bring better trading and payments capabilities together within one ecosystem.
About smartTrade Technologies
smartTrade Technologies provides end-to-end private SaaS solutions for financial markets, supporting varied asset classes including FX, fixed income, crypto, and derivatives. Also, the company specializes in hosted services that facilitate liquidity management, risk management, order processing, and payment solutions.
About Celoxica
Celoxica is a UK-based financial technology company founded in 1996 as a spin-off from the University of Oxford. Oxford University's technology transfer organisation, Isis Innovation, helped establish the company, with Ian Page playing a key role in its development. Now, Celoxica specialises in ultra-low latency electronic trading technology.
Wrapping Up
The acquisition expands smartTrade's capabilities beyond its current trading, FX derivatives, and payments solutions. Now, the Group can support multiple OTC and listed market activities and keep current client relationships and operations intact.
Register your company now and get featured on our homepage!